Technology | July 25, 2011

RFID Tracking and Verification System Featured at AAPM

July 25, 2011 – Civco Medical Solutions is showcasing its RFSuite radio frequency identification (RFID) tracking and verification system at the annual meeting of the American Association of Physicists in Medicine (AAPM). Civco also is hosting an RFSuite Symposium, from 12:30 – 2 p.m Monday, Aug. 1, in the Mackenzie Ballroom at the Fairmont Waterfront, Vancouver. The event will include lunch. Pre-registration is required, and spots are still available.

The symposium will include several speakers experienced with RFID technology, including Todd Pawlicki, Ph.D., director of medical physics and clinical operations at Moores Cancer Center in San Diego, Calif., and Alfredo Siochi, Ph.D., assistant professor and director of medical physics education in the department of radiation oncology at the University of Iowa Hospital and Clinics in Iowa City, Iowa. Moores Cancer Center has been using Civco’s RFSuite for nearly a year.

Civco will also sponsor an RFID and workflow consortium at AAPM to learn more about the clinical benefits of RF technology.  

The RFSuite system uses RFID technology to track patients, staff and equipment and to provide accessory and patient identity verification for treatment. “The use of RFID technology provides real-time information about resource availability and pending tasks,” said Siochi. “Schedule optimization could match resources to tasks and in our RFID simulation study, this reduced patient wait times by 30 minutes.”

The RFSuite software, RFTrak, provides a snapshot of where people and items are located in a facility in real time, improving workflow and reducing patient wait time. Civco’s RFSeries line provides a broad array of RFID enabled products.

“RFID technology is uniquely positioned to have a major impact in radiation oncology,” said Pawlicki. “In addition to equipment and resource tracking, RFID will provide the real-time process data that can be used as the basis for comprehensive performance and safety programs. We look forward to working with Civco in developing its RFID technology as a key component of our data-driven improvement approaches, such as Lean or Six Sigma.”

For more information: www.Civco.com

Related Content

The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...
An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

Diagram showing details of the lung screening experiment. Image courtesy of the European Respiratory Society/Benoit Audelan

News | Artificial Intelligence | September 08, 2021
September 8, 2021 — An artificial intell...